| Proposed regulatory framework for modifications to artificial intelligence/machine learning (AI/ML)-based software as a medical device (SaMD) Food and Drug Administration Department of Health and Human Services (United States), 2019 | 372 | 2019 |
| Using digital health technology to better generate evidence and deliver evidence-based care A Sharma, RA Harrington, MB McClellan, MP Turakhia, ZJ Eapen, ... Journal of the American College of Cardiology 71 (23), 2680-2690, 2018 | 305 | 2018 |
| FDA regulation of mobile medical apps J Shuren, B Patel, S Gottlieb Jama 320 (4), 337-338, 2018 | 148 | 2018 |
| Digital biomarkers: convergence of digital health technologies and biomarkers S Vasudevan, A Saha, ME Tarver, B Patel NPJ digital medicine 5 (1), 36, 2022 | 89 | 2022 |
| Proposed regulatory framework for modifications to artificial intelligence/machine learning (AI/ML)-based software as a medical device (SaMD): discussion paper and request for … US FDA US Food Drug Adm, 1-20, 2019 | 70 | 2019 |
| Foundational considerations for artificial intelligence using ophthalmic images MD Abràmoff, B Cunningham, B Patel, MB Eydelman, T Leng, ... Ophthalmology 129 (2), e14-e32, 2022 | 52 | 2022 |
| Advancing digital health: FDA innovation during COVID-19 K Kadakia, B Patel, A Shah Npj Digital Medicine 3 (1), 161, 2020 | 51 | 2020 |
| Software as a medical device (SaMD) US Food and Drug Administration Clinical, 2022 | 47 | 2022 |
| based Software as a Medical Device (SaMD) action plan A Intelligence, M Learning Food and Drug Administration, 2021-06, 2021 | 42 | 2021 |
| Software as a medical device (SaMD): key definitions IMDRF SaMD Working Group International Medical Device Regulators Forum, 1-9, 2013 | 42 | 2013 |
| General wellness: Policy for low risk devices US Food and Drug Administration Fed. Reg 81, 49993-49995, 2016 | 35 | 2016 |
| Software as a medical device (SAMD): clinical evaluation–guidance for industry and Food and Drug Administration staff US Food and Drug Administration FDA: Silver Spring, MD, 2017 | 23 | 2017 |
| Software as a medical device”: possible framework for risk categorization and corresponding considerations IMDRF SaMD Working Group International Medical Device Regulators Forum, 2014 | 22 | 2014 |
| Remote digital monitoring for medical product development ES Izmailova, JA Wagner, N Ammour, N Amondikar, A Bell‐Vlasov, ... Clinical and translational science 14 (1), 94-101, 2021 | 18 | 2021 |
| Software as a medical device (SaMD): clinical evaluation IMDRF SaMD Working Group Int Med Device Regul Forum, 4-8, 2017 | 15 | 2017 |
| Recent advances in systems and network medicine: meeting report from the first international conference in systems and network medicine E Kurnat-Thoma, A Baranova, P Baird, E Brodsky, AJ Butte, AK Cheema, ... Systems Medicine 3 (1), 22-35, 2020 | 12 | 2020 |
| FDASIA health IT report: Proposed strategy and recommendations for a risk-based framework US Food and Drug Administration Washington, DC: US Food and Drug Administration, 2014 | 9 | 2014 |
| Collaborative Community on Ophthalmic Imaging Executive Committee and Foundational Principles of Ophthalmic Imaging and Algorithmic Interpretation Working Group. Foundational … MD Abràmoff, B Cunningham, B Patel, MB Eydelman, T Leng, ... Ophthalmology 129 (2), e14-32, 2022 | 8 | 2022 |
| Digital biomarkers: convergence of digital health technologies and biomarkers. NPJ Digital Medicine, 5 (1), 36 S Vasudevan, A Saha, ME Tarver, B Patel Number 1, 1-3, 2022 | 7 | 2022 |
| IMDRF WG SaMD | 6 | 2013 |
Mintu Turakhia MD MASProfessor of Medicine; Founder and Director, Center for Digital Health, Stanford University; Chief在 stanford.edu 的电子邮件经过验证
